(Feb. 7, 2011) New Orleans -- The number of nonmelanomaskin cancers continues to rise, with an estimated 3.7 million cases in the U.S. in 2009.
That's the latest figure from researchers who last year reported that more than 2 million Americans were treated for 3.5 million nonmelanoma skin cancers -- mainly basal cell and squamous cell carcinomas -- in 2006.
Although these skin cancers can be easily treated if detected early, "the long-established culture of tanning is creating a huge public health problem," says Brett M. Coldiron, MD, clinical associate professor of dermatology at the University of Cincinnati.
"We need to admit there's an epidemic," he tells WebMD.
For both studies, Coldiron and colleagues used Medicare claims data to count the number of skin cancer removal procedures among Medicare recipients and extrapolated figures to the rest of the population.
Their earlier report, published last year in the Archives of Dermatology, showed skin cancer removals among Medicare patients increased on average 4% a year from 1992 to 2006.
The new findings, presented at the annual meeting of the American Academy of Dermatology (AAD), showed that procedures among Medicare patients increased an additional 2.4% from 2006 to 2007, 2.6% from 2007-2008, and an additional 1.6% in 2009.
For Many, Damage Is Done
What's worse, the numbers may continue to rise, says AAD President Ronald L. Moy, MD, professor of dermatology at the University of California Los Angeles David Geffen School of Medicine.
That's because there is often a lag time of 20 years or more between sun damage and manifestations of skin cancer, he tells WebMD.
"For many baby boomers, the damage has already been done," Coldiron says. "Think back to the days when people used to lather baby oil all over their skin."
"If we keep going like this, there will be a doubling of [nonmelanoma] skin cancers in the next 15 to 20 years," Coldiron says.
Most Accurate Figures to Date
"The cost of all these cases is tremendous," Coldiron says. Diagnosis and treatment of each cancer tops $2,000, bringing the total cost of the 3.7 million cases in 2009 to more than $8.6 billion.